85 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
and CKD EMPA-REG ... SGLT2i in HF and CKD ... DAPA-CKD - Dapagliflozin ... visualabstract #table ... #CVD #CKD
Definitions of AKI, CKD, AKD
Acute Kidney Injury (AKI):
 • Increase in SCr by 2 50% within
Definitions of AKI, CKD ... Kidney Disease (CKD ... per 1.73 m2 • Stable ... /CKD • No structural ... damage #AKI #CKD
Gout Management in CKD
 • Colchicine
 • NSAID
 • Glucocorticoid
 • ACTH
 • Interleukin-1 Inhibitors

#Gout #Management
Management in CKD ... Gout #Management #CKD ... rheumatology #treatment #comparison
Mirizzi Syndrome on RUQ POCUS

Adult male-RUQ abd pain.VSS/Afeb. WBC-16.8K. Obstructive pattern on hepatic panel with normal
Adult male-RUQ abd ... MRCP performed. ... biliary tree(can be CHD ... or CBD that is
Causes of Polyneuropathy - Differential Diagnosis Algorithm
 • Metabolic: DM, Hypothyroidism, CKD, Cirrhosis, Nutritional deficiency
 •
Differential Diagnosis Algorithm ... Hypothyroidism, CKD ... Paraneoplastic, CTD ... Differential #Diagnosis #Algorithm
Oral Antihypertensive Medications - Selection by Comorbidities
Comorbidities: 
 • Stable Angina, HFpEF, HFrEF, AFib, TAA/Marfan, Aortic
Comorbidities: • Stable ... Dissection • CKD ... , DM, ESRD, PKD ... #pharmacology #table
Common Bile Duct Biliary Stone removal on ERCP

Dr. Joaquín Berrueta Mezzera @DrJBerrueta

#Biliary #Stone #removal #extraction #ERCP
Stone removal on ERCP ... removal #extraction #ERCP ... gastroenterology #cbd
Pharmacokinetics of commonly used diuretics medications in CKD, Cirrhotic Ascites, and Heart Failure
 • Furosemide
 •
medications in CKD ... Pharmacokinetics #halflife #comparison ... #table
Resistant Hypertension in CKD - Diagnosis and Management Algorithm

#Resistant #Hypertension #CKD #Diagnosis #Management #Algorithm
Hypertension in CKD ... and Management Algorithm ... #Hypertension #CKD ... Diagnosis #Management #Algorithm
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Medications Summary Table ... Improved outcomes in CKD ... #medications #table ... #comparison #management